Effector Therapeutics Inc
(EFTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,834 | -35,811 | -26,681 | -18,378 | -10,014 |
| Depreciation Amortization | -32 | -362 | -291 | -142 | -91 |
| Other Working Capital | 479 | 1,685 | -743 | -222 | 1,210 |
| Other Operating Activity | 1,109 | 4,938 | 3,731 | 2,513 | 1,258 |
| Operating Cash Flow | $-7,278 | $-29,550 | $-23,984 | $-16,229 | $-7,637 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,821 | -17,169 | -17,169 | -13,256 | -2,960 |
| PPE Investments | N/A | -97 | -43 | -41 | -13 |
| Sale Of Investment | 3,500 | 31,750 | 22,750 | 20,750 | 12,000 |
| Investing Cash Flow | $-6,321 | $14,484 | $5,538 | $7,453 | $9,027 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -556 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 14,788 | 21,233 | 15,124 | 14,782 | 212 |
| Financing Cash Flow | $14,232 | $21,233 | $15,124 | $14,782 | $212 |
| Beginning Cash Position | 14,875 | 8,708 | 8,708 | 8,708 | 8,708 |
| End Cash Position | 15,508 | 14,875 | 5,386 | 14,714 | 10,310 |
| Net Cash Flow | $633 | $6,167 | $-3,322 | $6,006 | $1,602 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,278 | -29,550 | -23,984 | -16,229 | -7,637 |
| Capital Expenditure | N/A | -97 | -43 | -41 | -13 |
| Free Cash Flow | -7,278 | -29,647 | -24,027 | -16,270 | -7,650 |